<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The treatment for systemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JRA</z:e> is among actual problems of pediatric rheumatology </plain></SENT>
<SENT sid="1" pm="."><plain>To evaluate the effectiveness of pulse therapy (PT) with <z:chebi fb="0" ids="6888">methylprednisolone</z:chebi> 25-30 mg/kg/day for 3 consecutive days combined with <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> 0.4-0.5 g/sq. m body surface area (BSA) on the 3rd day, repeated quarterly for 12 months, 30 patients with systemic <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">JRA</z:e> were randomized into 3 groups: 1--those with disease duration (DD) less than 2 years receiving PT (n = 13), 2--with DD 2 years and more (n = 8) receiving PT, and 3--with DD less than 2 years receiving no PT </plain></SENT>
<SENT sid="2" pm="."><plain>Children in <z:hpo ids='HP_0000001'>all</z:hpo> 3 groups received concomitant medication (one of <z:chebi fb="2" ids="35475">nonsteroidal anti-inflammatory drugs</z:chebi>, <z:chebi fb="0" ids="44185">methotrexate</z:chebi> 10 mg/sq. m BSA/week and oral steroids) </plain></SENT>
<SENT sid="3" pm="."><plain>A rapid and significant improvement, according to systemic and articular manifestations as well as laboratory indices occurred in the 1st group, in most of the measured parameters exceeded effects in the other two groups and gave the opportunity to avoid the administration of oral steroids or to give the lesser initial dose </plain></SENT>
<SENT sid="4" pm="."><plain>Side effects were minor and completely reversible </plain></SENT>
</text></document>